Orli Even-Or
Director of R&D Coltac Therapeutics
Seminars
Thursday 29th January 2026
Advancing Molecular Glue Discovery through a Positive-Signal Bacterial Screening Platform
11:30 am
- Combining in-silico with the power of our bacteria-based, synthetic positive selection screening system for new molecular glues
- Program insights covering oncology and non-oncology programs, with focus on ligase diversity, target specificity, and optimization process
- Future directions that include expanding beyond degraders to explore non-degraders and PPI modulators, supporting both scientific advancement and company growth strategy
